Skip to main content

Anemia - Sickle Cell News (Page 3)

Related terms: Hemoglobin SS disease (Hb SS), Sickle Cell Anemia, Hemoglobin SS disease, Hb SS, SCD

FDA Approves Adakveo (crizanlizumab-tmca) to Reduce Frequency of Pain Crises in Individuals Living with Sickle Cell Disease

Basel, November 15, 2019 – Novartis announced today that the US Food and Drug Administration (FDA) approved Adakveo (crizanlizumab), previously known as SEG101, to reduce the frequency of v...

FDA Approves Endari (L-glutamine oral powder) for Sickle Cell Disease

July 7, 2017 – The U.S. Food and Drug Administration today approved Endari (L-glutamine oral powder) for patients age five years and older with sickle cell disease to reduce severe complications...

Ask a question

To post your own question to our community, sign in or create an account.